Sagent Pharmaceuticals Announces the Launch of Acetazolamide for Injection, USP

[at noodls] – SCHAUMBURG, Ill., Nov. 13, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Acetazolamide for Injection, USP, the generic form of the carbonic anhydrase … more

View todays social media effects on SGNT

View the latest stocks trending across Twitter. Click to view dashboard